1	Conjunctival	Conjunctival	B-NP	NNP	O	5	SUB
2	scarring	scar	B-VP	VBG	O	1	NMOD
3	in	in	B-PP	IN	O	2	VMOD
4	trachoma	trachoma	B-NP	NN	O	3	PMOD
5	is	be	B-VP	VBZ	O	0	ROOT
6	associated	associate	I-VP	VBN	O	5	VC
7	with	with	B-PP	IN	O	6	VMOD
8	the	the	B-NP	DT	O	10	NMOD
9	HLA-C	HLA-C	I-NP	NN	B-protein	10	NMOD
10	ligand	ligand	I-NP	NN	I-protein	7	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	KIR	KIR	B-NP	NN	B-protein	11	PMOD
13	and	and	O	CC	O	5	VMOD
14	is	be	B-VP	VBZ	O	5	VMOD
15	exacerbated	exacerbate	I-VP	VBN	O	14	VC
16	by	by	B-PP	IN	O	15	VMOD
17	heterozygosity	heterozygosity	B-NP	NN	O	16	PMOD
18	at	at	B-PP	IN	O	17	NMOD
19	KIR2DL2/KIR2DL3	KIR2DL2/KIR2DL3	B-NP	NN	O	18	PMOD
20	.	.	O	.	O	5	P

1	Chlamydia	Chlamydia	B-NP	NN	O	2	NMOD
2	trachomatis	trachomatis	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	globally	globally	B-ADVP	RB	O	3	VMOD
5	the	the	B-NP	DT	O	8	NMOD
6	predominant	predominant	I-NP	JJ	O	8	NMOD
7	infectious	infectious	I-NP	JJ	O	8	NMOD
8	cause	cause	I-NP	NN	O	3	PRD
9	of	of	B-PP	IN	O	8	NMOD
10	blindness	blindness	B-NP	NN	O	9	PMOD
11	and	and	O	CC	O	3	VMOD
12	one	one	B-NP	CD	O	11	PRD
13	of	of	B-PP	IN	O	12	NMOD
14	the	the	B-NP	DT	O	18	NMOD
15	most	most	I-NP	RBS	O	17	AMOD
16	common	common	I-NP	JJ	O	17	AMOD
17	bacterial	bacterial	I-NP	JJ	O	18	NMOD
18	causes	cause	I-NP	NNS	O	13	PMOD
19	of	of	B-PP	IN	O	18	NMOD
20	sexually	sexually	B-NP	RB	O	21	AMOD
21	transmitted	transmit	I-NP	VBN	O	22	NMOD
22	infection	infection	I-NP	NN	O	19	PMOD
23	.	.	O	.	O	3	P

1	Infections	Infection	B-NP	NNS	O	5	SUB
2	of	of	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	4	NMOD
4	conjunctiva	conjunctiva	I-NP	NN	O	2	PMOD
5	cause	cause	B-VP	VBP	O	0	ROOT
6	the	the	B-NP	DT	O	9	NMOD
7	blinding	blind	I-NP	VBG	O	9	NMOD
8	disease	disease	I-NP	NN	O	9	NMOD
9	trachoma	trachoma	I-NP	NN	O	13	NMOD
10	,	,	O	,	O	13	P
11	an	an	B-NP	DT	O	13	NMOD
12	immuno-pathological	immuno-pathological	I-NP	JJ	O	13	NMOD
13	disease	disease	I-NP	NN	O	5	OBJ
14	that	that	B-NP	WDT	O	13	NMOD
15	is	be	B-VP	VBZ	O	14	SBAR
16	characterised	characterise	I-VP	VBN	O	15	VC
17	by	by	B-PP	IN	O	16	VMOD
18	chronic	chronic	B-NP	JJ	O	20	NMOD
19	conjunctival	conjunctival	I-NP	JJ	O	20	NMOD
20	inflammation	inflammation	I-NP	NN	O	22	NMOD
21	and	and	I-NP	CC	O	22	NMOD
22	fibrosis	fibrosis	I-NP	NN	O	17	PMOD
23	.	.	O	.	O	5	P

1	The	The	B-NP	DT	O	5	NMOD
2	polymorphic	polymorphic	I-NP	JJ	B-protein	5	NMOD
3	Killer-cell	Killer-cell	I-NP	NN	I-protein	5	NMOD
4	Immunoglobulin-like	Immunoglobulin-like	I-NP	JJ	I-protein	5	NMOD
5	Receptors	Receptor	I-NP	NNS	I-protein	9	SUB
6	(	(	O	(	O	8	DEP
7	KIR	KIR	B-NP	NN	B-protein	8	DEP
8	)	)	O	)	O	5	NMOD
9	are	be	B-VP	VBP	O	0	ROOT
10	found	find	I-VP	VBN	O	9	VC
11	on	on	B-PP	IN	O	10	VMOD
12	Natural	Natural	B-NP	JJ	B-cell_type	14	NMOD
13	Killer	Killer	I-NP	NN	I-cell_type	14	NMOD
14	cells	cell	I-NP	NNS	I-cell_type	11	PMOD
15	and	and	O	CC	O	9	VMOD
16	have	have	B-VP	VBP	O	9	VMOD
17	co-evolved	co-evolve	I-VP	VBN	O	16	VC
18	with	with	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	22	NMOD
20	Human	Human	I-NP	JJ	B-protein	22	NMOD
21	Leucocyte	Leucocyte	I-NP	NN	I-protein	22	NMOD
22	Antigen	Antigen	I-NP	NN	I-protein	28	NMOD
23	(	(	O	(	O	25	DEP
24	HLA	HLA	B-NP	NN	O	25	DEP
25	)	)	O	)	O	22	NMOD
26	class	class	B-NP	NN	O	28	NMOD
27	I	I	I-NP	CD	O	28	NMOD
28	system	system	I-NP	NN	O	18	PMOD
29	.	.	O	.	O	9	P

1	Certain	Certain	B-NP	JJ	O	3	NMOD
2	genetic	genetic	I-NP	JJ	O	3	NMOD
3	constellations	constellation	I-NP	NNS	O	11	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	KIR	KIR	B-NP	NN	B-protein	10	NMOD
6	and	and	I-NP	CC	O	10	NMOD
7	HLA	HLA	I-NP	NN	B-protein	10	NMOD
8	class	class	I-NP	NN	I-protein	10	NMOD
9	I	I	B-NP	CD	I-protein	10	NMOD
10	polymorphisms	polymorphism	I-NP	NNS	O	4	PMOD
11	are	be	B-VP	VBP	O	0	ROOT
12	associated	associate	I-VP	VBN	O	11	VC
13	with	with	B-PP	IN	O	12	VMOD
14	a	a	B-NP	DT	O	15	NMOD
15	number	number	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	diseases	disease	B-NP	NNS	O	16	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	which	which	B-NP	WDT	O	18	PMOD
20	modulation	modulation	B-NP	NN	O	31	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	innate	innate	I-NP	JJ	O	24	NMOD
24	responses	response	I-NP	NNS	O	21	PMOD
25	to	to	B-PP	TO	O	24	NMOD
26	viral	viral	B-NP	JJ	O	30	NMOD
27	and	and	I-NP	CC	O	30	NMOD
28	intracellular	intracellular	I-NP	JJ	O	30	NMOD
29	bacterial	bacterial	I-NP	JJ	O	30	NMOD
30	pathogens	pathogen	I-NP	NNS	O	25	PMOD
31	is	be	B-VP	VBZ	O	18	SBAR
32	central	central	B-ADJP	JJ	O	31	PRD
33	.	.	O	.	O	11	P

1	A	A	B-NP	DT	O	2	NMOD
2	sample	sample	I-NP	NN	O	21	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	134	134	B-NP	CD	O	6	NMOD
5	Gambian	Gambian	I-NP	JJ	O	6	NMOD
6	pedigrees	pedigree	I-NP	NNS	O	3	PMOD
7	selected	select	B-VP	VBN	O	6	NMOD
8	to	to	B-VP	TO	O	9	VMOD
9	contain	contain	I-VP	VB	O	7	VMOD
10	at	at	B-NP	IN	O	13	NMOD
11	least	least	I-NP	JJS	O	10	AMOD
12	one	one	I-NP	CD	O	10	AMOD
13	individual	individual	I-NP	NN	O	9	OBJ
14	with	with	B-PP	IN	O	9	VMOD
15	conjunctival	conjunctival	B-NP	JJ	O	16	NMOD
16	scarring	scarring	I-NP	NN	O	14	PMOD
17	in	in	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	20	NMOD
19	F1	F1	I-NP	NN	O	20	NMOD
20	generation	generation	I-NP	NN	O	17	PMOD
21	was	be	B-VP	VBD	O	0	ROOT
22	used	use	I-VP	VBN	O	21	VC
23	.	.	O	.	O	21	P

1	Individuals	Individual	B-NP	NNS	O	5	SUB
2	(	(	O	(	O	4	DEP
3	n = 830	n = 830	B-NP	NN	O	4	DEP
4	)	)	O	)	O	1	NMOD
5	were	be	B-VP	VBD	O	0	ROOT
6	genotyped	genotype	I-VP	VBN	O	5	VC
7	for	for	B-PP	IN	O	6	VMOD
8	HLA	HLA	B-NP	NN	B-protein	14	NMOD
9	class	class	I-NP	NN	I-protein	14	NMOD
10	I	I	I-NP	CD	I-protein	9	NMOD
11	and	and	I-NP	CC	O	14	NMOD
12	KIR	KIR	I-NP	NN	O	14	NMOD
13	gene	gene	I-NP	NN	O	14	NMOD
14	families	family	I-NP	NNS	O	7	PMOD
15	.	.	O	.	O	5	P

1	Family	Family	B-NP	NNP	O	8	NMOD
2	Based	Based	I-NP	NNP	O	3	NMOD
3	Association	Association	I-NP	NNP	O	8	NMOD
4	Tests	Test	I-NP	NNPS	O	3	NMOD
5	and	and	O	CC	O	8	NMOD
6	Case	Case	B-NP	NNP	O	7	NMOD
7	Pseudo-control	Pseudo-control	I-NP	NNP	O	8	NMOD
8	tests	test	I-NP	NNS	O	9	SUB
9	were	be	B-VP	VBD	O	0	ROOT
10	used	use	I-VP	VBN	O	9	VC
11	to	to	B-VP	TO	O	12	VMOD
12	extend	extend	I-VP	VB	O	10	VMOD
13	tests	test	B-NP	NNS	O	12	OBJ
14	for	for	B-PP	IN	O	13	NMOD
15	transmission	transmission	B-NP	NN	O	16	NMOD
16	disequilibrium	disequilibrium	I-NP	NN	O	29	NMOD
17	to	to	B-VP	TO	O	18	VMOD
18	take	take	I-VP	VB	O	16	NMOD
19	full	full	B-NP	JJ	O	20	NMOD
20	advantage	advantage	I-NP	NN	O	18	OBJ
21	of	of	B-PP	IN	O	20	NMOD
22	the	the	B-NP	DT	O	24	NMOD
23	family	family	I-NP	NN	O	24	NMOD
24	design	design	I-NP	NN	O	21	PMOD
25	,	,	O	,	O	29	P
26	genetic	genetic	B-NP	JJ	O	27	NMOD
27	model	model	I-NP	NN	O	29	NMOD
28	and	and	I-NP	CC	O	29	NMOD
29	phenotype	phenotype	I-NP	NN	O	14	PMOD
30	.	.	O	.	O	9	P

1	We	We	B-NP	PRP	O	2	SUB
2	found	find	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	odds	odd	I-NP	NNS	O	9	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	trachomatous	trachomatous	B-NP	JJ	O	8	NMOD
8	scarring	scarring	I-NP	NN	O	6	PMOD
9	increased	increase	B-VP	VBD	O	29	VMOD
10	with	with	B-PP	IN	O	9	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	number	number	I-NP	NN	O	10	PMOD
13	of	of	B-PP	IN	O	12	NMOD
14	genome	genome	B-NP	NN	O	15	NMOD
15	copies	copy	I-NP	NNS	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	HLA-C2	HLA-C2	B-NP	NN	B-protein	16	PMOD
18	(	(	O	(	O	26	DEP
19	C1/C2	C1/C2	B-NP	NN	O	21	NMOD
20	OR = 2.29	OR = 2.29	I-NP	NN	O	21	NMOD
21	BHP-value = 0.006	BHP-value = 0.006	I-NP	NN	O	25	NMOD
22	;	;	O	:	O	25	P
23	C2/C2	C2/C2	B-NP	NN	O	25	NMOD
24	OR = 3.97	OR = 3.97	I-NP	NN	O	25	NMOD
25	BHP-value = 0.0004	BHP-value = 0.0004	I-NP	NN	O	26	DEP
26	)	)	O	)	O	17	NMOD
27	and	and	O	CC	O	9	VMOD
28	further	further	B-ADVP	RBR	O	29	VMOD
29	increased	increase	B-VP	VBD	O	3	SBAR
30	when	when	B-ADVP	WRB	O	29	VMOD
31	both	both	O	CC	O	34	NMOD
32	KIR2DL2	KIR2DL2	B-NP	NN	O	34	NMOD
33	and	and	O	CC	O	34	NMOD
34	KIR2DL3	KIR2DL3	B-NP	NN	O	40	SUB
35	(	(	O	(	O	39	DEP
36	C2/C2	C2/C2	B-NP	NN	O	38	NMOD
37	OR = 5.95	OR = 5.95	I-NP	NN	O	38	NMOD
38	BHP-value = 0.006	BHP-value = 0.006	I-NP	NN	O	39	DEP
39	)	)	O	)	O	34	NMOD
40	were	be	B-VP	VBD	O	30	SBAR
41	present	present	B-ADJP	JJ	O	40	PRD
42	.	.	O	.	O	2	P

1	To	To	B-VP	TO	O	2	VMOD
2	explain	explain	I-VP	VB	O	14	VMOD
3	the	the	B-NP	DT	O	4	NMOD
4	observations	observation	I-NP	NNS	O	2	OBJ
5	in	in	B-PP	IN	O	4	NMOD
6	the	the	B-NP	DT	O	7	NMOD
7	context	context	I-NP	NN	O	5	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	chlamydial	chlamydial	B-NP	JJ	O	10	NMOD
10	infection	infection	I-NP	NN	O	12	NMOD
11	and	and	I-NP	CC	O	12	NMOD
12	trachoma	trachoma	I-NP	NN	O	8	PMOD
13	we	we	B-NP	PRP	O	14	SUB
14	propose	propose	B-VP	VBP	O	0	ROOT
15	a	a	B-NP	DT	O	17	NMOD
16	two-stage	two-stage	I-NP	JJ	O	17	NMOD
17	model	model	I-NP	NN	O	14	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	response	response	B-NP	NN	O	21	NMOD
20	and	and	I-NP	CC	O	21	NMOD
21	disease	disease	I-NP	NN	O	18	PMOD
22	that	that	B-NP	WDT	O	21	NMOD
23	balances	balance	B-VP	VBZ	O	22	SBAR
24	the	the	B-NP	DT	O	26	NMOD
25	cytolytic	cytolytic	I-NP	JJ	O	26	NMOD
26	response	response	I-NP	NN	O	23	OBJ
27	of	of	B-PP	IN	O	26	NMOD
28	KIR	KIR	B-NP	NN	B-protein	27	PMOD
29	expressing	express	B-VP	VBG	O	28	NMOD
30	NK	NK	B-NP	NN	B-cell_type	31	NMOD
31	cells	cell	I-NP	NNS	I-cell_type	29	OBJ
32	with	with	B-PP	IN	O	29	VMOD
33	the	the	B-NP	DT	O	34	NMOD
34	ability	ability	I-NP	NN	O	41	NMOD
35	to	to	B-VP	TO	O	36	VMOD
36	secrete	secrete	I-VP	VB	O	34	NMOD
37	interferon	interferon	B-NP	NN	B-protein	38	NMOD
38	gamma	gamma	I-NP	NN	I-protein	36	OBJ
39	,	,	O	,	O	41	P
40	a	a	B-NP	DT	O	41	NMOD
41	combination	combination	I-NP	NN	O	32	PMOD
42	that	that	B-NP	WDT	O	41	NMOD
43	may	may	B-VP	MD	O	42	SBAR
44	cause	cause	I-VP	VB	O	43	VC
45	pathology	pathology	B-NP	NN	O	44	OBJ
46	.	.	O	.	O	14	P

1	The	The	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	4	SUB
3	presented	present	B-VP	VBN	O	2	NMOD
4	indicate	indicate	B-VP	VBP	O	0	ROOT
5	that	that	B-SBAR	IN	O	17	DEP
6	HLA-C	HLA-C	B-NP	NN	B-protein	7	NMOD
7	genotypes	genotype	I-NP	NNS	I-protein	8	SUB
8	are	be	B-VP	VBP	O	5	SBAR
9	important	important	B-NP	JJ	O	10	NMOD
10	determinants	determinant	I-NP	NNS	O	8	PRD
11	of	of	B-PP	IN	O	10	NMOD
12	conjunctival	conjunctival	B-NP	JJ	O	13	NMOD
13	scarring	scarring	I-NP	NN	O	11	PMOD
14	in	in	B-PP	IN	O	10	NMOD
15	trachoma	trachoma	B-NP	NN	O	14	PMOD
16	and	and	O	CC	O	17	DEP
17	that	that	B-SBAR	IN	O	4	VMOD
18	KIR2DL2/KIR2DL3	KIR2DL2/KIR2DL3	B-NP	NN	O	19	NMOD
19	heterozygosity	heterozygosity	I-NP	NN	O	21	SUB
20	further	further	B-ADVP	RBR	O	21	VMOD
21	increases	increase	B-VP	VBZ	O	17	SBAR
22	risk	risk	B-NP	NN	O	21	OBJ
23	of	of	B-PP	IN	O	22	NMOD
24	conjunctival	conjunctival	B-NP	JJ	O	25	NMOD
25	scarring	scarring	I-NP	NN	O	23	PMOD
26	in	in	B-PP	IN	O	22	NMOD
27	individuals	individual	B-NP	NNS	O	26	PMOD
28	carrying	carry	B-VP	VBG	O	27	NMOD
29	HLA-C2	HLA-C2	B-NP	NN	B-protein	28	OBJ
30	.	.	O	.	O	4	P

